Merck & Company Inc (MRK)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 4,538,000 -2,574,000 -633,000 -11,926,000 -13,809,000 -8,463,000 -10,244,000 -41,000 1,965,000 3,890,000 4,765,000 1,828,000 -1,314,000 -10,863,000 -12,556,000 -11,169,000 -9,969,000 -1,971,000 -4,146,000 -4,282,000
Revenue (ttm) US$ in thousands 64,168,000 63,174,000 62,479,000 61,402,000 60,114,000 59,314,000 58,311,000 57,869,000 59,283,000 58,974,000 57,169,000 53,978,000 48,704,000 46,131,000 43,906,000 41,857,000 43,287,000 36,488,000 37,956,000 40,363,000
Operating profit margin 7.07% -4.07% -1.01% -19.42% -22.97% -14.27% -17.57% -0.07% 3.31% 6.60% 8.33% 3.39% -2.70% -23.55% -28.60% -26.68% -23.03% -5.40% -10.92% -10.61%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $4,538,000K ÷ $64,168,000K
= 7.07%

The operating profit margin of Merck & Company Inc has exhibited significant variability over the periods presented. It started off at negative levels in March 2020 and continued to be negative until December 2021, with the margin reaching its lowest point of -28.60% in June 2021. However, there was a notable improvement in the operating profit margin in the subsequent quarters, turning positive in March 2022 at 3.39% and peaking at 8.33% in June 2022.

Following this positive trend, the operating profit margin fluctuated around the positive territory up to December 2024, demonstrating a rebound in profitability. Despite experiencing some declines in certain quarters, such as the negative margin in June 2023, the overall trend indicates a recovery and improvement in the company's operational efficiency.

It is essential for stakeholders to closely monitor Merck & Company Inc's operating profit margin to assess its ability to generate profits from its core business operations and sustain profitability in the long term.


See also:

Merck & Company Inc Operating Profit Margin (Quarterly Data)